6S Pharma is dedicated to improving patient outcomes by focusing on the development and delivery of high-quality pharmaceutical products. The company employs innovative strategies to evaluate and repurpose approved drugs, addressing unmet medical needs. Their expertise in formulation and clinical development allows them to create unique, value-added solutions tailored to patient requirements. With a diverse portfolio that includes both 505(B)(2) and 505(J) products, 6S Pharma balances risk while targeting substantial market needs, particularly in areas exceeding $2 billion.

The company is also expanding its focus into complex generics, showcasing a commitment to strategic growth and innovation in healthcare. By leveraging their proficiency in repurposing existing drugs, 6S Pharma aims to create a dynamic and value-centric portfolio that aligns with high-demand healthcare areas. Their approach includes preparing for Investigational New Drug (IND) applications and conducting human proof-of-concept studies, further emphasizing their dedication to transforming healthcare through unique solutions and effective global marketing strategies.

United States

An early stage start-up with three products in Pre-IND phase and several complex generics in the pipeline.

6S Pharma

Company Details